Logiscreen

SI-BONE Inc

$15.12
Market Cap 667.78M
ROE -9.6%
Gross Margin 79.8%
Debt/Equity 0.2
Current Ratio 10.0
Revenue QoQ 11.2%
EPS QoQ -0.3%
F-Score 4

About

SI-BONE is a global leader in technology for the surgical treatment of sacropelvic disorders. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 4,000 surgeons in performing more than 110,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 140 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-39.36
vs median 31.50
P/B
3.67
vs median 2.17
ROE
-0.10
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics